Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Murray

Showing results (531-540 of 594) with videos related to

Pageof 60
Sort By:
Psychological Medicine|March 4, 2020
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control studyHannah E Jongsma, Charlotte Gayer-Anderson, Ilaria Tarricone, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 2018
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disordersMaria Stella Calafato, Johan H Thygesen, Siri Ranlund, et al.
BMJ (Clinical Research Ed.)|August 30, 2023
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studiesMarco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 15, 2025
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiquesBenjamin W Bond, Bea Duric, Edoardo Spinazzola, et al.
Schizophrenia Research|March 31, 2023
Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort studyEdward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
Schizophrenia Research|July 30, 2024
Corrigendum to "Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study" [Schizophr. Res. volume 225 (May 2023) 173-181]Edward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 30, 2017
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domainsSiri Ranlund, Stella Calafato, Johan H Thygesen, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Acta Psychiatrica Scandinavica|November 1, 2024
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Giada Tripoli, et al.
The Lancet. Psychiatry|March 24, 2019
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control studyMarta Di Forti, Diego Quattrone, Tom P Freeman, et al.
Pageof 60

Showing results (531-540 of 594) with videos related to

Sort By:
Pageof 60
Psychological Medicine|March 4, 2020
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control studyHannah E Jongsma, Charlotte Gayer-Anderson, Ilaria Tarricone, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 2018
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disordersMaria Stella Calafato, Johan H Thygesen, Siri Ranlund, et al.
BMJ (Clinical Research Ed.)|August 30, 2023
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studiesMarco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 15, 2025
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiquesBenjamin W Bond, Bea Duric, Edoardo Spinazzola, et al.
Schizophrenia Research|March 31, 2023
Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort studyEdward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
Schizophrenia Research|July 30, 2024
Corrigendum to "Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study" [Schizophr. Res. volume 225 (May 2023) 173-181]Edward Millgate, Sophie E Smart, Antonio F Pardiñas, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 30, 2017
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domainsSiri Ranlund, Stella Calafato, Johan H Thygesen, et al.
Schizophrenia Bulletin|May 4, 2026
Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI StudyCraig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, et al.
Acta Psychiatrica Scandinavica|November 1, 2024
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI studyGiuseppe D'Andrea, Diego Quattrone, Giada Tripoli, et al.
The Lancet. Psychiatry|March 24, 2019
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control studyMarta Di Forti, Diego Quattrone, Tom P Freeman, et al.
Pageof 60